1. Home
  2. SAGE vs BCAL Comparison

SAGE vs BCAL Comparison

Compare SAGE & BCAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAGE
  • BCAL
  • Stock Information
  • Founded
  • SAGE 2010
  • BCAL 2001
  • Country
  • SAGE United States
  • BCAL United States
  • Employees
  • SAGE N/A
  • BCAL N/A
  • Industry
  • SAGE Biotechnology: Pharmaceutical Preparations
  • BCAL Major Banks
  • Sector
  • SAGE Health Care
  • BCAL Finance
  • Exchange
  • SAGE Nasdaq
  • BCAL Nasdaq
  • Market Cap
  • SAGE 571.1M
  • BCAL 460.6M
  • IPO Year
  • SAGE 2014
  • BCAL N/A
  • Fundamental
  • Price
  • SAGE $9.12
  • BCAL $16.41
  • Analyst Decision
  • SAGE Hold
  • BCAL Strong Buy
  • Analyst Count
  • SAGE 18
  • BCAL 1
  • Target Price
  • SAGE $9.89
  • BCAL $20.00
  • AVG Volume (30 Days)
  • SAGE 1.8M
  • BCAL 150.2K
  • Earning Date
  • SAGE 07-30-2025
  • BCAL 07-28-2025
  • Dividend Yield
  • SAGE N/A
  • BCAL N/A
  • EPS Growth
  • SAGE N/A
  • BCAL N/A
  • EPS
  • SAGE N/A
  • BCAL 0.62
  • Revenue
  • SAGE $47,404,000.00
  • BCAL $132,045,000.00
  • Revenue This Year
  • SAGE $101.71
  • BCAL $74.16
  • Revenue Next Year
  • SAGE $42.30
  • BCAL $4.92
  • P/E Ratio
  • SAGE N/A
  • BCAL $26.33
  • Revenue Growth
  • SAGE N/A
  • BCAL 42.63
  • 52 Week Low
  • SAGE $4.62
  • BCAL $11.87
  • 52 Week High
  • SAGE $13.47
  • BCAL $18.49
  • Technical
  • Relative Strength Index (RSI)
  • SAGE 66.62
  • BCAL 67.61
  • Support Level
  • SAGE $9.10
  • BCAL $16.05
  • Resistance Level
  • SAGE $9.36
  • BCAL $16.74
  • Average True Range (ATR)
  • SAGE 0.10
  • BCAL 0.41
  • MACD
  • SAGE -0.09
  • BCAL -0.00
  • Stochastic Oscillator
  • SAGE 29.69
  • BCAL 83.19

About SAGE Sage Therapeutics Inc.

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.

About BCAL Southern California Bancorp

California BanCorp is a registered bank holding company headquartered in San Diego, California. The Bank offers a range of financial products and services to individuals, professionals, and small to medium-sized businesses through its 14 branch offices and four loan production offices serving Northern and Southern California. The Bank's solutions-driven, relationship-based approach to banking provides accessibility to decision-makers and enhances value through partnerships with its clients. The company has one operating segment: Commercial Banking.

Share on Social Networks: